TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35247264

Group type: EXPERIMENTAL
Intervention: BCG vaccine (n = 1008)
Number of subjects: 2014

Group type: COMPARATOR
Intervention: Placebo (n = 1006)
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 2014
Study: 32839967

Group type: EXPERIMENTAL
Intervention: Proposed method for conditional power estimation in CRTs with correlated interval-censored data.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies to evaluate the proposed method.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of the method on a large cluster-randomized HIV prevention trial.
Number of subjects: 0
Study: 34651239

Group type: EXPERIMENTAL
Intervention: Subcutaneous wound irrigation with 0.04% polyhexanide
Number of subjects: 456

Group type: COMPARATOR
Intervention: Subcutaneous wound irrigation with 0.9% saline
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Patients with SSI
Number of subjects: 456

Group type: COMPARATOR
Intervention: Patients without SSI
Number of subjects: 456
Study: 34096182

Group type: EXPERIMENTAL
Intervention: LungVision system for peripheral pulmonary nodule biopsy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: LungVision system
Number of subjects: 63
Study: 34914889

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg intravenously every 2 weeks)
Number of subjects: 743

Group type: COMPARATOR
Intervention: Sorafenib (400 mg orally twice daily)
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 743

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 743
Study: 35575641

Group type: EXPERIMENTAL
Intervention: Orthognathic surgery
Number of subjects: 65
Study: 32879983

Group type: EXPERIMENTAL
Intervention: Base diet consisting of the IAA provided at the RDA plus addition of individual DAAs to meet a 50:50 ratio of IAA:DAA on an N basis.
Number of subjects: 7

Group type: COMPARATOR
Intervention: Diets corresponding to the amino acid pattern present in egg protein with all Glu and Gln present as Glu, or removed, with Ser used to make the diets isonitrogenous.
Number of subjects: 7
Study: 34853360

Group type: EXPERIMENTAL
Intervention: Active diode laser
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 42
Study: 32331433

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 28
Study: 36066977

Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg subcutaneously) once weekly for 26 weeks
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg subcutaneously) once weekly for 26 weeks in a subgroup of obese patients
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 34931772

Group type: EXPERIMENTAL
Intervention: Navigation group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Navigation group (for STs with bone thickness > 0.5 mm)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (for STs with bone thickness > 0.5 mm)
Number of subjects: 24
Study: 35689257

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33009192

Group type: EXPERIMENTAL
Intervention: TCI‐PCA with target plasma concentrations between 0.8 and 10 ng/ml
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCA with bolus doses of 0.2 mg
Number of subjects: 50
Study: 36096886

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) treatment during the postoperative period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular exercise training
Number of subjects: 0
Study: 34120336

Group type: EXPERIMENTAL
Intervention: Gabapentin (3600 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35658544

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham surgery with intermittent fasting and calorie restriction (SH-IF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham surgery ad libitum (SH-AL)
Number of subjects: 0
Study: 34472893

Group type: EXPERIMENTAL
Intervention: Shamiri-Digital (online single-session intervention for depression)
Number of subjects: 103
Study: 33359134

Group type: EXPERIMENTAL
Intervention: TTFM (Transit-Time Flow Measurement)
Number of subjects: 1568

Group type: COMPARATOR
Intervention: Non-TTFM
Number of subjects: 1568

Group type: EXPERIMENTAL
Intervention: TTFM
Number of subjects: 1568
Study: 34427047

Group type: EXPERIMENTAL
Intervention: Family-focused therapy for clinical high risk youth (FFT-CHR) - 18 1-hour sessions of family psychoeducation and communication/problem-solving skills training
Number of subjects: 220

Group type: COMPARATOR
Intervention: Enhanced care - 3 1-hour family psychoeducational sessions followed by 5 individual support sessions
Number of subjects: 220
Study: 34541650

Group type: EXPERIMENTAL
Intervention: Interdisciplinary and diversified health education combined with personalized nutrition intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 180
Study: 35843465

Group type: EXPERIMENTAL
Intervention: His Bundle Pacing (HBP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Biventricular Pacing (BVP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both HBP and BVP
Number of subjects: 50
Study: 34406128

Group type: EXPERIMENTAL
Intervention: 6% Hydroxyethyl Starch 130/0.4
Number of subjects: 135

Group type: COMPARATOR
Intervention: 5% human albumin
Number of subjects: 135
Study: 36066501

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injections, 50 units into both hands
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo injections into both hands
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injections
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 90
Study: 33839787

Group type: EXPERIMENTAL
Intervention: Amlodipine (maximum 20 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prazosin GITS (maximum 30 mg)
Number of subjects: 20
Study: 36113111

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 469

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 469
Study: 32138661

Group type: EXPERIMENTAL
Intervention: 25 mg/L GO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IAA (> 0.5 mg/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GO and IAA cotreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: GO alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GO treatment
Number of subjects: 0
Study: 34501915

Group type: COMPARATOR
Intervention: Exergames training (ETG)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Exergames combined with protein supplementation (ETPSG)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Protein supplementation (PSG)
Number of subjects: 90
Study: 34210187

Group type: EXPERIMENTAL
Intervention: Distraction condition (distracting concurrent task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no distracting task)
Number of subjects: 0
Study: 33139038

Group type: EXPERIMENTAL
Intervention: BCAA-enriched diet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard hospital meals (Control)
Number of subjects: 57
Study: 32238920

Group type: EXPERIMENTAL
Intervention: Ki-67 response-guided arm (Ki-67 arm)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control arm (standard chemotherapy)
Number of subjects: 237
Study: 35157835

Group type: EXPERIMENTAL
Intervention: Baricitinib plus standard of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 0
Study: 35970681

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl patches (TFP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-opioid analgesics (NSAIDs)
Number of subjects: 48
Study: 33058773

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBMT) using a neodymium‐doped YAG (Nd: YAG) laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no PBMT)
Number of subjects: 20
Study: 36141665

Group type: EXPERIMENTAL
Intervention: Integrated Program for Early Childhood Development (comprehensive early development interventions via bi-weekly home visiting activities and monthly family group activities)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated Program for Early Childhood Development
Number of subjects: 0
Study: 34189864

Group type: EXPERIMENTAL
Intervention: Moxibustion treatment for 8 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham moxibustion treatment for 8 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study: 35017774

Group type: EXPERIMENTAL
Intervention: Early administration of dexmedetomidine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Late administration of dexmedetomidine
Number of subjects: 81
Study: 33000357

Group type: EXPERIMENTAL
Intervention: Food Addiction at M12
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Food Addiction Scores at M12
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Binge Eating at M12
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Food Addiction Prevalence
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Binge Eating Prevalence Pre-surgery
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Food Addiction Prevalence Pre-surgery
Number of subjects: 54
Study: 34910080

Group type: EXPERIMENTAL
Intervention: Multifaceted prevention intervention including structured delirium education, daily assessment of delirium risk factors, and tailored prevention strategies (cognitive, motor, sensory stimulation, etc.)
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1470

Group type: EXPERIMENTAL
Intervention: Multifaceted prevention intervention
Number of subjects: 1470
Study: 32602445

Group type: EXPERIMENTAL
Intervention: DCDQ-ES (Developmental Coordination Disorder Questionnaire - European Spanish version)
Number of subjects: 31
Study: 35190292

Group type: EXPERIMENTAL
Intervention: Tezacaftor/ivacaftor
Number of subjects: 130
Study: 34029650

Group type: EXPERIMENTAL
Intervention: Surgical hand scrub with nail brush for 2 minutes (Group III)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Surgical hand scrub without nail brush for 2 minutes (Group IV)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Surgical hand scrub with nail brush for 1 minute (Group I)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Surgical hand scrub without nail brush for 1 minute (Group II)
Number of subjects: 180
Study: 34913487

Group type: EXPERIMENTAL
Intervention: Multiple Family Therapy (MFT) for 3 months
Number of subjects: 76
Study: 35715802

Group type: EXPERIMENTAL
Intervention: Gracey Curette
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: After Five Curette
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mini Five Curette
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 32572020

Group type: EXPERIMENTAL
Intervention: 40IU self‐administered intranasal oxytocin (OT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35157053

Group type: EXPERIMENTAL
Intervention: Early Treatment Study (remote trial)
Number of subjects: 1410

Group type: EXPERIMENTAL
Intervention: Remote trial online recruitment
Number of subjects: 1410
Study: 33638020

Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional ultrasound-guided PCNL
Number of subjects: 160
Study: 32163509

Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy (BBAT) plus Treatment as Usual (TAU)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Mixed Physical Activity (MPA) plus Treatment as Usual (TAU)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 338
Study: 32449418

Group type: EXPERIMENTAL
Intervention: Topical clobetasol plus oral low dose naltrexone (3 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Topical clobetasol plus placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: Comparison between LDN and placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low dose naltrexone (3 mg)
Number of subjects: 34
Study: 33771664

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dabrafenib/Trametinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipilimumab and Nivolumab (combined therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/Ipilimumab
Number of subjects: 0
Study: 35947455

Group type: EXPERIMENTAL
Intervention: Screw fixation (2 x 3.5‐mm partially threaded cannulated screws)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Suture button fixation (2 surgical buttons)
Number of subjects: 10
Study: 34816053

Group type: EXPERIMENTAL
Intervention: On-demand auditory cueing and instructions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Feedback about physical activity using the wearable DeFOG system
Number of subjects: 62
Study: 35872584

Group type: EXPERIMENTAL
Intervention: Group A: Isoniazid 15 mg/kg and rifapentine 750/900 mg weekly for 8 weeks.
Number of subjects: 2583

Group type: EXPERIMENTAL
Intervention: Group B: Isoniazid [600-(50-body weight)×15] (rounded up) and rifapentine 600/450 mg twice a week for 6 weeks.
Number of subjects: 2583
Study: 33945885

Group type: EXPERIMENTAL
Intervention: Firearm storage device with training (offered at no or low cost)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care (observation phase)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Firearm storage device with training (among those not practicing TSS at baseline)
Number of subjects: 256
Study: 34687290

Group type: EXPERIMENTAL
Intervention: Contrast framing
Number of subjects: 284

Group type: COMPARATOR
Intervention: Connect framing
Number of subjects: 284

Group type: COMPARATOR
Intervention: Neutral framing
Number of subjects: 284
Study: 32421229

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) treatment
Number of subjects: 50
Study: 35978435

Group type: EXPERIMENTAL
Intervention: Multimodal shift-work intervention including healthy scheduling, education program, and information campaign for shift planners.
Number of subjects: 160
Study: 33118716

Group type: EXPERIMENTAL
Intervention: rFSH
Number of subjects: 168

Group type: COMPARATOR
Intervention: hMG
Number of subjects: 168
Study: 32865576

Group type: EXPERIMENTAL
Intervention: Student Bodies‐Eating Disorders, a digital CBT‐guided self‐help program
Number of subjects: 690

Group type: COMPARATOR
Intervention: Referral to usual care
Number of subjects: 690
Study: 35559249

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF) 2,400 mg daily during prevention cycles
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF) during acute episodes
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 32383347

Group type: EXPERIMENTAL
Intervention: Personalised printed and mobile-accessible discharge instructions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual pain relief discharge advice
Number of subjects: 80
Study: 33558721

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ipilimumab plus nivolumab
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High tumor mutational burden (TMB) and high interferon-gamma-related gene expression signature score (IFN-γ score)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard adjuvant therapy with antibodies against PD-1 (proposed for future study)
Number of subjects: 95
Study: 32473649

Group type: EXPERIMENTAL
Intervention: Lidocaine + Propofol (L + P)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Normal Saline + Propofol (NS + P)
Number of subjects: 79
Study: 35527573

Group type: EXPERIMENTAL
Intervention: Emergency nursing and monitoring procedure
Number of subjects: 134

Group type: COMPARATOR
Intervention: Normal nursing procedure
Number of subjects: 134
Study: 33026551

Group type: EXPERIMENTAL
Intervention: Automatic cartilage segmentation using KneeCaP software
Number of subjects: 91

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Mild‐to‐moderate OA group
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Severe OA group
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Mild‐to‐moderate OA group vs Severe OA group
Number of subjects: 91
Study: 33006191

Group type: EXPERIMENTAL
Intervention: Dietary energy (10.12 MJ/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary energy (10.90 MJ/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary energy (11.68 MJ/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary energy (varied)
Number of subjects: 36
Study: 36135037

Group type: EXPERIMENTAL
Intervention: Exercise training (EX)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resistance training during AC taper week
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Periodized exercise approach
Number of subjects: 28
Study: 34915907

Group type: EXPERIMENTAL
Intervention: Patients with higher reverse T3 (rT3) compared to controls (p=0.0002)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Patients with lower T3/rT3 compared to controls (p=0.0012)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Patients had higher IGFBP3 compared to controls (p=0.030)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Lower T3/rT3 associated with lower handgrip strength and shorter 6-min walk distance (p≤0.036)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Higher IGFBP3 associated with higher handgrip strength (p=0.031)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Comparable serum concentrations of thyroid hormones and binding proteins between patients and controls
Number of subjects: 436

Group type: COMPARATOR
Intervention: Comparable concentrations of growth hormone, IGF-I, and IGFBP1 between patients and controls
Number of subjects: 436

Group type: COMPARATOR
Intervention: Comparable total and free cortisol, cortisol-binding globulin, and albumin concentrations between patients and controls
Number of subjects: 436
Study: 36407843

Group type: EXPERIMENTAL
Intervention: Oxycodone/Naloxone Prolonged Release (OXN PR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxycodone Prolonged Release (Oxy PR)
Number of subjects: 0
Study: 32272281

Group type: EXPERIMENTAL
Intervention: WeChat-based multimodal nursing program plus routine nursing care for 6 months
Number of subjects: 111

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 111
Study: 34510077

Group type: EXPERIMENTAL
Intervention: Measuring group (pedicle measuring technique)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Control group (conventional DIEP flap technique)
Number of subjects: 389
Study: 33075179

Group type: EXPERIMENTAL
Intervention: L-arginine (100 mg/kg TID)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 32493211

Group type: EXPERIMENTAL
Intervention: Modified dose of 0.5% isobaric bupivacaine in group U
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 ml of 0.5% isobaric bupivacaine in group C
Number of subjects: 60
Study: 36015163

Group type: EXPERIMENTAL
Intervention: Kan Jang® (daily dose of andrographolides—90 mg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Kan Jang®
Number of subjects: 86
Study: 33741696

Group type: EXPERIMENTAL
Intervention: IADPSG criteria for diagnosing GDM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response to treatment at different diagnostic thresholds of maternal glycemia
Number of subjects: 0
Study: 36078296

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HEX) at 80% 1-RM
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-moderate-intensity resistance training (LEX) at 50% 1-RM
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 40
Study: 34217283

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 168
Study: 35057841

Group type: EXPERIMENTAL
Intervention: Near real-time data-driven recruitment approach using NHS Test and Trace service
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Public consultation regarding the use of test data for recruitment
Number of subjects: 2639
Study: 34469857

Group type: EXPERIMENTAL
Intervention: RAY (Rhythms And You)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RAY-CH (RAY with clinical helper support)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Adjunctive Reading Material (ARM)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RAY-CH
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RAY
Number of subjects: 47
Study: 34349181

Group type: EXPERIMENTAL
Intervention: High sodium intake (mean 24-h sodium excretion of 3834 mg)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Caloric intake
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Overweight/obese with hypertension
Number of subjects: 582
Study: 32114617

Group type: EXPERIMENTAL
Intervention: Delirium
Number of subjects: 73

Group type: COMPARATOR
Intervention: No Delirium
Number of subjects: 73
Study: 35841202

Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 2321
Study: 34127107

Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/d)
Number of subjects: 306
Study: 32878606

Group type: EXPERIMENTAL
Intervention: Injection time < 180 s
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Injection time 180-300 s
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Injection time > 300 s
Number of subjects: 70

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 70
Study: 33152542

Group type: EXPERIMENTAL
Intervention: Saroglitazar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 33667460

Group type: EXPERIMENTAL
Intervention: Continuous Serratus Anterior Plane Block (SAPB) in combination with intravenous flurbiprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (Control)
Number of subjects: 0